why choose us

300×250 Ad Slot

Research Article: Tacrolimus Trough Level Variation and Its Correlation to Clinical Outcomes and Consequences in Solid Organ Transplantation

Date Published: 2023-08-08

Introduction:
Tacrolimus (TAC) has been the primary agent as immunosuppressive agent in solid organ transplants since the s. It is a potent calcineurin inhibitor that suppresses cellular immunity by inhibiting T-lymphocyte activation where it has a significant contribution to considerable five-year survival rates after a solid organ transplant. , Compared to the other calcineurin inhibitor, cyclosporine, TAC is known to provide higher organ and patient survival rates. Therefore, it leads to lower rejection rates and higher span…

Read more

300×250 Ad Slot